Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer

The results of this meta-analysis suggest that, for men with localized prostate cancer treated with definitive radiotherapy and ADT, there are relative and absolute benefits from increasing durations of ADT that help provide individualized risk estimates.

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2025-11-20
DOI
https://doi.org/10.1001/jamaoncol.2025.4800
Citations
2
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer

Gerhardt Attard, Theo M. de Reijke, William A. Hall, Yilun Sun et al.
2 citations
JAMA Oncology
Prostate Cancer Diagnosis and Treatment
3.04
article

Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer

Gerhardt Attard, Theo M. de Reijke, William A. Hall, Yilun Sun, Paul Linh Nguyen, Thomas M. Pisansky, Nathalie Carrier, David Joseph, Carmen González‐San Segundo, Luís Souhami, Scott Carlyle Morgan, Shawn Malone, Josep María Macias i Solé, Robert Timothy Dess, Abdenour Nabid, Angela Y. Jia, Adam Calaway, Amar U. Kishan, Jonathan Evan Shoag, Luca Valle, Ting Martin, Matthew B. Rettig, Jason A. Efstathiou, Charles Gillham, Pedro Coelho Barata, Jason Robert Brown, Matthew J. Schipper, Tahmineh Romero, Prateek Mendiratta, M. Bolla, Will Jackson, Michael L. Steinberg, Daniel Eidelberg Spratt, Soumyajit Roy, P. Maingon, Nicholas George Zaorsky, Allison Steigler, María Ángeles Cabeza Rodríguez, Randy Vince, A. Guerrero, A. Alvarez Gonzalez, Jorge Alberto Garcia, John G. Armstrong, Howard M. Sandler, Almudena Zapatero, Agustí Pedro Olivé, C.A. Lawton
article en
2 citations

Abstract

The results of this meta-analysis suggest that, for men with localized prostate cancer treated with definitive radiotherapy and ADT, there are relative and absolute benefits from increasing durations of ADT that help provide individualized risk estimates.

JAMA OncologyVol. 12(1)
Cedars-Sinai Medical Center (US), Mayo Clinic (US), Harvard University (US), University of Ottawa (CA), University of California, Los Angeles (US), The University of Western Australia (AU), University of Washington (US), Medical College of Wisconsin (US), University of Michigan (US), Centre Hospitalier Universitaire de Grenoble (FR), Ottawa Hospital (CA), McGill University Health Centre (CA), Centre Hospitalier Universitaire de Sherbrooke (CA), Hospital General Universitario Gregorio Marañón (ES), Sorbonne Université (FR), Massachusetts General Hospital (US), Hospital Terrassa (ES), Hospital Universitario 12 De Octubre (ES), Cancer Trials Ireland (IE), University Hospitals Seidman Cancer Center (US), Mútua Terrassa (ES), Hospital Universitario de La Princesa (ES), Hospital Plató (ES), Amsterdam University Medical Centers (NL), Hospital Universitario Son Espases (ES), VA Greater Los Angeles Healthcare System (US), Dana-Farber Brigham Cancer Center (US), Rush University (US), Case Western Reserve University (US), University of Newcastle Australia (AU), University of Amsterdam (NL)
Openalex Percentile: Top 7%
Prostate Cancer Diagnosis and Treatment
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.